These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35449163)

  • 21. Biosafety in DIY-bio laboratories: from hype to policy: Discussions about regulating DIY biology tend to ignore the extent of self-regulation and oversight of DIY laboratories.
    Sundaram LS
    EMBO Rep; 2021 Apr; 22(4):e52506. PubMed ID: 33761157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidelines for research involving recombinant DNA molecules.
    U.S. National Institutes of Health
    Fed Regist; 1980 Jan; 45(20):6723-49. PubMed ID: 11664126
    [No Abstract]   [Full Text] [Related]  

  • 23. Specifications of standards in systems and synthetic biology: status and developments in 2020.
    Schreiber F; Sommer B; Czauderna T; Golebiewski M; Gorochowski TE; Hucka M; Keating SM; König M; Myers C; Nickerson D; Waltemath D
    J Integr Bioinform; 2020 Jun; 17(2-3):. PubMed ID: 32598316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recoded organisms engineered to depend on synthetic amino acids.
    Rovner AJ; Haimovich AD; Katz SR; Li Z; Grome MW; Gassaway BM; Amiram M; Patel JR; Gallagher RR; Rinehart J; Isaacs FJ
    Nature; 2015 Feb; 518(7537):89-93. PubMed ID: 25607356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant DNA research; proposed revised guidelines.
    U.S. National Institutes of Health
    Fed Regist; 1981 Dec; 46(233):59368-425. PubMed ID: 11655483
    [No Abstract]   [Full Text] [Related]  

  • 26. Review of biosafety guidelines. Biosafety Task Force, Parenteral Drug Association.
    J Parenter Sci Technol; 1989; 43(6):252-8. PubMed ID: 2600729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biosafety considerations in handling medically important fungi.
    Padhye AA; Bennett JE; McGinnis MR; Sigler L; Fliss A; Salkin IF
    Med Mycol; 1998; 36 Suppl 1():258-65. PubMed ID: 9988515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biosafety standards for working with Crimean-Congo hemorrhagic fever virus.
    Weidmann M; Avsic-Zupanc T; Bino S; Bouloy M; Burt F; Chinikar S; Christova I; Dedushaj I; El-Sanousi A; Elaldi N; Hewson R; Hufert FT; Humolli I; Jansen van Vuren P; Koçak Tufan Z; Korukluoglu G; Lyssen P; Mirazimi A; Neyts J; Niedrig M; Ozkul A; Papa A; Paweska J; Sall AA; Schmaljohn CS; Swanepoel R; Uyar Y; Weber F; Zeller H
    J Gen Virol; 2016 Nov; 97(11):2799-2808. PubMed ID: 27667586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biosafety news: introducing EBSA--the European Biosafety Association.
    Biotechnol J; 2007 Mar; 2(3):285. PubMed ID: 17354214
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthetic biology: Building genetic containment.
    Haynes KA
    Nat Chem Biol; 2016 Feb; 12(2):55-6. PubMed ID: 26784843
    [No Abstract]   [Full Text] [Related]  

  • 31. [Biosafety provision on handling pathogenic biological agents on the concept of biorisk assessment and management].
    Dobrokhotskiĭ ON; Kolombet LV
    Gig Sanit; 2010; (5):79-81. PubMed ID: 21344700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experiences from the implementation of a biosafety system in Slovenia.
    Milavec M; Racman DS
    Biotechnol J; 2007 Sep; 2(9):1093-104. PubMed ID: 17703486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on Biosafety and Emerging Infections for the Clinical Microbiology Laboratory.
    Pentella MA
    Clin Lab Med; 2020 Dec; 40(4):473-482. PubMed ID: 33121616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant DNA research: actions under guidelines.
    U.S. National Institutes of Health
    Fed Regist; 1984 Nov; 49(227):46256-63. PubMed ID: 11655641
    [No Abstract]   [Full Text] [Related]  

  • 35. The Main Biological Hazards in Animal Biosafety Level 2 Facilities and Strategies for Control.
    Li XY; Xue KN; Jiang JS; Lu XC
    Biomed Environ Sci; 2016 Apr; 29(4):300-4. PubMed ID: 27241742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant DNA research: proposed revised guidelines.
    U.S. National Institutes of Health
    Fed Regist; 1978 Jul; 43(146):33042-178. PubMed ID: 11663829
    [No Abstract]   [Full Text] [Related]  

  • 37. Practical biosafety in the tuberculosis laboratory: containment at the source is what truly counts.
    van Soolingen D; Wisselink HJ; Lumb R; Anthony R; van der Zanden A; Gilpin C
    Int J Tuberc Lung Dis; 2014 Aug; 18(8):885-9. PubMed ID: 25199000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common sense in genetic engineering.
    Harris R
    Ethics Sci Med; 1978; 5(2-4):57-64. PubMed ID: 11662705
    [No Abstract]   [Full Text] [Related]  

  • 39. U. of Michigan sets stringent DNA controls.
    Sci Gov Rep; 1976 Jun; 6(10):8. PubMed ID: 11661423
    [No Abstract]   [Full Text] [Related]  

  • 40. Biosafety practices in pathology laboratories.
    Isouard G
    Aust Health Rev; 1988; 11(2):122-9. PubMed ID: 10290491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.